Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.35 |
| ▸ | MME | P08473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14604365 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL29891666 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL30822978 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL30629016 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL10856404 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL29630376 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL30159237 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL29519255 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL30712894 | 1.00 | SLC15A2 (0.35) | SLC15A2MME | |
| SCHEMBL23598223 | 0.97 | MME (0.35) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230322900-A1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | BIOVERATIV THERAPEUTICS INC (US) | 2023-10-12 | — | — | US | disclosed |
| EP-4194465-A1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Bioverativ Therapeutics Inc. (US) | 2023-06-14 | — | — | EP | disclosed |
| CN-114699506-A | Use of recombinant calreticulin for growing hair, protecting hair or preventing alopecia and related products | 北京百华百汇生物科技有限公司 | 2022-07-05 | — | — | CN | disclosed |
| US-20200087379-A1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | BIOVERATIV THERAPEUTICS INC (US) | 2020-03-19 | — | — | US | disclosed |
| EP-2814840-B1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | BIOVERATIV THERAPEUTICS INC (US) | 2019-11-13 | — | — | EP | disclosed |
| EP-3564260-A1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Bioverativ Therapeutics Inc. (US) | 2019-11-06 | — | — | EP | disclosed |
| US-10421798-B2 | Factor VIII compositions and methods of making and using same | BIOVERATIV THERAPEUTICS INC. (US) | 2019-09-24 | — | — | US | disclosed |
| EP-3339325-A1 | BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC | UCB Biopharma SPRL (BE) | 2018-06-27 | — | — | EP | disclosed |
| US-9957328-B2 | Bacterial host strain expressing recombinant DSBC | UCB PHARMA, S.A. (GB) | 2018-05-01 | — | — | US | disclosed |
| US-20170335003-A1 | BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC | CELLTECH R&D LTD. (GB) | 2017-11-23 | — | — | US | disclosed |
| EP-2731973-B1 | BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC | UCB BIOPHARMA SPRL (BE) | 2017-11-15 | — | — | EP | disclosed |
| US-9725516-B2 | Bacterial host strain expressing recombinant DSBC | UCB PHARMA, S.A. (BE) | 2017-08-08 | — | — | US | disclosed |
| US-20150158929-A1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | AMUNIX OPERATING INC. (US) | 2015-06-11 | — | — | US | disclosed |
| CN-104487452-A | Factor viii compositions and methods of making and using same | AMUNIX OPERATING INC | 2015-04-01 | — | — | CN | disclosed |
| EP-2814840-A1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | Amunix Operating Inc. (US) | 2014-12-24 | — | — | EP | disclosed |
| US-20140141468-A1 | BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC | UCB PHARMA, S.A. (BE) | 2014-05-22 | — | — | US | disclosed |
| EP-2731973-A1 | BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC | UCB Pharma, S.A. (BE) | 2014-05-21 | — | — | EP | disclosed |
| WO-2013122617-A1 | FACTOR VIII COMPOSITIONS AND METHODS OF MAKING AND USING SAME | AMUNIX OPERATING INC. (US) | 2013-08-22 | — | — | WO | disclosed |
| WO-2013007388-A1 | BACTERIAL HOST STRAIN EXPRESSING RECOMBINANT DSBC | UCB PHARMA, S.A. (BE) | 2013-01-17 | — | — | WO | disclosed |